SRT2183
| CAS No. | 1001908-89-9 | Cat. No. | BCP37408 |
| Name | SRT2183 | ||
| Synonyms | SRT 2183; SRT-2183; | ||
| Formula | C27H24N4O2S | M. Wt | 468.57 |
| Description | SRT2183 is a Sirt1 activator, currently being developed by Sirtris Pharmaceuticals. SRT2183 has similar activity in the body to another SIRT1 activator SRT1720 , but is closer in potency to resveratrol. In animal studies it was found to improve insulin sensitivity and lower plasma glucose levels in fat, muscle and liver tissue, and increased mitochondrial and metabolic function. However, the claim that SRT2183 is a SIRT1 activator has been questioned and further defended. | ||
| Pathways | Cell Cycle/DNA Damage Epigenetics | ||
| Targets | Sirtuin | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.